COVID-19
Malaria prophylactic tafenoquine shows antiviral activity against SARS-CoV-2 in cell cultures
July 14, 2020Manufacturing and Production, Research and Development 60 Degrees Pharmaceuticals, COVID-19, coronavirus, pharma
Specialist tropical disease drug firm 60 Degrees Pharmaceuticals has revealed that its therapy Arakoda (tafenoquine) has been shown in cell …
Arthritis drug reduces COVID-19 deaths for patients on ventilators
July 14, 2020Manufacturing and Production COVID-19, coronavirus
The rheumatoid arthritis drug tocilizumab reduces death rates in coronavirus patients on ventilation, according to new studies.
Pfizer and BioNTech’s COVID-19 vaccines to have their development fast tracked by the FDA
July 14, 2020Manufacturing and Production, Research and Development COVID-19, Vaccine, coronavirus
The FDA has granted Pfizer and BioNTech’s COVID-19 vaccine candidates Fast Track status to speed up their development and review. …
Itolizumab “significantly reduced mortality” in hospitalised COVID-19 patients with respiratory distress, secures emergency use authorisation in India
July 13, 2020Research and Development, Sales and Marketing COVID-19, Itolizumab, coronavirus
Itolizumab, a drug currently being developed by biotech firm Equillium for autoimmune and inflammatory disorders, “significantly reduced mortality” in hospitalised …
WHO reports record daily increase in global COVID-19 cases
July 13, 2020Sales and Marketing COVID-19, coronavirus
The World Health Organization reported the largest daily increase in COVID-19 cases since the pandemic began. Over the weekend there …
Russia claims it has completed the first human trial for COVID-19 vaccine
July 13, 2020Sales and Marketing COVID-19, coronavirus, vaccines
Russia has become the first country to complete a COVID-19 vaccine trial on humans, according to the Russian News Agency. …
Remdesivir cuts death risk by 62% in coronavirus patients, new study shows
July 13, 2020Sales and Marketing COVID-19, coronavirus
Gilead’s remdesivir reduced the risk of death in 62% of severe COVID-19 patients, according to a new study. The company …
New data shows Gilead’s remdesivir “potently inhibited” SARS-CoV-2 in human lung cell cultures
July 10, 2020Medical Communications, Research and Development COVID-19, Gilead, coronavirus, remdesivir
New findings published from researchers at Vanderbilt University Medical Center (VUMC) at the University of North Carolina, as well as …
Scientists warn of brain damage linked to COVID-19
July 10, 2020Medical Communications COVID-19, Neurological, coronavirus
COVID-19 could lead to a wave of brain damage in people who were infected with the virus. Experts at the …
The World Health Organization says COVID-19 can linger in the air indoors
July 10, 2020Medical Communications COVID, COVID-19, WHO, coronavirus
The World Health Organization has recoginised that COVID-19 can be transmitted indoors by droplets in the air, reversing its previous …
Majority of people who test positive for COVID-19 have no symptoms, according to ONS study
July 9, 2020Business Services COVID-19, coronavirus, testing
Most people who test positive for COVID-19 do not have symptoms of the virus when tested, according to the Office …
COVID-19 impact on England’s cancer services could lead to 35,000 excess deaths
July 8, 2020Research and Development COVID-19, Cancer, England, coronavirus
New data emerging from DATA-CAN: The Health Data Research Hub for Cancer has shone a light on the potential toll …
Trump moves to formally remove the US from the World Health Organization
July 8, 2020Research and Development COVID-19, Trump, WHO
President Donald Trump has formally moved to end the US membership of the World Health Organization. He has notified both …
Brazilian President Jair Bolsonaro tests positive for COVID-19, says he is taking hydroxychloroquine
July 8, 2020Research and Development Brazil, COVID-19, President of Brazil
Jair Bolsonaro, the President of Brazil, has tested positive for COVID-19 and says he treating the virus with hydroxychloroquine. The …
UK universities join forces for early-stage COVID-19 therapy testing platform
July 7, 2020Manufacturing and Production, Research and Development COVID-19, UK, coronavirus
A coalition of UK universities have come together to build a new clinical trial and drug testing platform to evaluate …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
